Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Nelson

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonistsHongyu Zhao, Zhili Xin, Jyoti R Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Calexcitin: a signaling protein that binds calcium and GTP, inhibits potassium channels, and enhances membrane excitabilityT J Nelson, S Cavallaro, C L Yi, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2006
Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain explorationBo Liu, Mei Liu, Zhili Xin, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2008
Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitorsZhili Xin, Hongyu Zhao, Michael D Serby, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Pyridone-containing farnesyltransferase inhibitors: synthesis and biological evaluationLisa A Hasvold, Weibo Wang, Stephen L Gwaltney, et al.
Journal of Medicinal Chemistry|July 21, 2006
Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitorsHongyu Zhao, Michael D Serby, Zhili Xin, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivativesStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potencyStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.
Journal of Medicinal Chemistry|April 14, 2006
2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonistsMichael D Serby, Hongyu Zhao, Bruce G Szczepankiewicz, et al.
Journal of Medicinal Chemistry|June 9, 2006
Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activityBruce G Szczepankiewicz, Christi Kosogof, Lissa T J Nelson, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonistsHongyu Zhao, Zhili Xin, Jyoti R Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Calexcitin: a signaling protein that binds calcium and GTP, inhibits potassium channels, and enhances membrane excitabilityT J Nelson, S Cavallaro, C L Yi, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2006
Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain explorationBo Liu, Mei Liu, Zhili Xin, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2008
Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitorsZhili Xin, Hongyu Zhao, Michael D Serby, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Pyridone-containing farnesyltransferase inhibitors: synthesis and biological evaluationLisa A Hasvold, Weibo Wang, Stephen L Gwaltney, et al.
Journal of Medicinal Chemistry|July 21, 2006
Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitorsHongyu Zhao, Michael D Serby, Zhili Xin, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivativesStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potencyStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.
Journal of Medicinal Chemistry|April 14, 2006
2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonistsMichael D Serby, Hongyu Zhao, Bruce G Szczepankiewicz, et al.
Journal of Medicinal Chemistry|June 9, 2006
Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activityBruce G Szczepankiewicz, Christi Kosogof, Lissa T J Nelson, et al.
Pageof 7